Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Naloxone NDA In US Gets Fast Track Status

Aug 11 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

US FDA’s Fast Track Designation Policy Faces Unusual Legal Challenge

Jun 03 2022

HRT Reports 'Remarkable Achievement' In OTC Naloxone Phase 1 Clinical Trial Results

Mar 01 2022

Drivers For Allowing OTC Naloxone In US Include Social Justice As Well As Public Health Need

Mar 31 2022

FDA Has Model Drug Facts Labels For OTC Naloxone, Wants Switch Proposals

Jan 18 2019

Additional Topics

International United States US States Prescription To OTC Switch FDA Deals Advertising, Marketing & Sales Business Strategies Commercial Clinical Trials Companies Compliance Consumer Drug Review Drug Safety Ingredients Manufacturing OTC Drugs OTC Devices Politics Policy Regulation

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window